CD44 and Splenomegaly: A 2023 study by Abobakr et al. [32] found that CD44 was expressed in 91.6% of malignant cells in pediatric BCP-ALL and was associated with poor prognostic factors, including high peripheral blood blast counts, hepatomegaly, splenomegaly, and reduced physical activity.